$505 Million is the total value of Centerbridge Partners's 17 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GTX | Sell | GARRETT MOTION INC | $326,981,640 | -13.9% | 38,065,383 | -0.3% | 64.77% | +6.4% |
| BANC | BANC OF CALIFORNIA INC | $77,926,817 | -16.0% | 6,097,560 | 0.0% | 15.44% | +3.8% | |
| Sell | REALOGY GRP LLC/REALOGY COnote 0.250% 6/1 | $51,881,706 | -31.6% | 64,582,000 | -32.5% | 10.28% | -15.5% | |
| GOHEALTH INCcl a new | $40,628,142 | -7.5% | 4,179,850 | 0.0% | 8.05% | +14.2% | ||
| DISH NETWORK CORPORATIONnote 12/1 | $5,513,270 | +0.7% | 7,500,000 | 0.0% | 1.09% | +24.4% | ||
| GDS | GDS HLDGS LTDsponsored ads | $1,904,181 | +39.7% | 204,971 | 0.0% | 0.38% | +72.1% | |
| UNITED HOMES GROUP INC*w exp 03/30/202 | $15,200 | -38.0% | 24,999 | 0.0% | 0.00% | -25.0% | ||
| PERFECT CORP*w exp 99/99/999 | $4,200 | -30.1% | 74,999 | 0.0% | 0.00% | 0.0% | ||
| BANZAI INTERNATIONAL INC*w exp 12/14/202 | $1,572 | -53.4% | 92,499 | 0.0% | 0.00% | -100.0% | ||
| Exit | GLOBAL GAS CORP DEL*w exp 12/21/202 | $0 | – | -149,999 | -100.0% | -0.00% | – | |
| BHC | Exit | BAUSCH HEALTH COS INCcall | $0 | – | -2,303,500 | -100.0% | -3.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Centerbridge Advisors III, LLC #1
- Centerbridge Credit Advisors, L.L.C. #2
- Centerbridge Partners Real Estate Advisors, LLC #3
- Centerbridge Partners Real Estate Advisors II, LLC #4
- Centerbridge Special Credit Advisors III, L.L.C. #5
- Aronson Jeffrey #6
- Centerbridge Partners Holdings, LLC #7
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
About Centerbridge Partners
Centerbridge Partners is a private investment management firm that was founded in 2005 by Mark Gallogly and Jeffrey Aronson. The firm is headquartered in New York City and has additional offices in London and Hong Kong. Centerbridge Partners manages over $25 billion in assets across a range of investment strategies, including private equity, distressed debt, and real estate.
The firm has a strong leadership team, with Mark Gallogly serving as the CEO and Jeffrey Aronson as the Chairman and Chief Investment Officer. The COO is William Rahm, who oversees the firm's operations and infrastructure.
Centerbridge Partners has a reputation for being a highly disciplined and opportunistic investor, with a focus on identifying undervalued assets and unlocking value through operational improvements. The firm has a track record of successfully investing in a range of industries, including healthcare, energy, and financial services.
One notable investment made by Centerbridge Partners was its acquisition of Syncora Holdings, a financial guarantee insurance company, in 2013. The firm was able to turn around the struggling company by implementing operational improvements and strategic initiatives, ultimately leading to a successful exit.
Overall, Centerbridge Partners is a well-respected investment management firm with a strong leadership team and a proven track record of success.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENCO SHIPPING & TRADING LTD | 26 | Q4 2022 | 18.0% |
| AMERICAN RENAL ASSOCS HLDGS | 19 | Q4 2020 | 34.8% |
| EXTENDED STAY AMER INC | 18 | Q4 2020 | 64.1% |
| AMBAC FINL GROUP INC | 17 | Q1 2018 | 4.8% |
| QUAD / GRAPHICS INC | 16 | Q4 2017 | 6.1% |
| IRSA INVERSIONES Y REP S A | 16 | Q3 2019 | 1.4% |
| ALLY FINL INC | 15 | Q4 2017 | 12.4% |
| GARRETT MOTION INC | 13 | Q2 2024 | 71.4% |
| GDS HLDGS LTD | 13 | Q2 2024 | 2.1% |
| WMIH CORP | 13 | Q3 2018 | 2.5% |
View Centerbridge Partners's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| KV PHARMACEUTICAL CO /DE/ | March 03, 2011 | ? | ? |
View Centerbridge Partners's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 40-APP/A | 2024-03-04 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 40-APP | 2023-10-16 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Centerbridge Partners's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.